Trial Profile
Effect of pioglitazone 15 mg or 30 mg on microcirculation in type 2 diabetes patients treated with insulin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Takeda Global Research and Development Center
- 04 Jun 2008 New trial record.